Evidence map›Paper›PMID 36635625›Full record

ArticleBMC medical research methodology2023

In search of a 'pan-European value set'; application for EQ-5D-3L.

Ayesha Sajjad, Matthijs M Versteegh, Irene Santi, Jan Busschbach, Judit Simon, Leona Hakkaart-van Roijen

Abstract read
In one paragraph

Article in BMC medical research methodology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Child- versus adult-perspective composite time trade-off valuations for the EQ-5D-Y-3L: evidence from the Hungarian valuation study.The European journal of health economics : HEPAC : health economics in prevention and care · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. In varietate concordia - cluster analysis of EQ-5D-5L value sets in European Union countries.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ayesha SajjadErasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands. ayesha_sajjad@hotmail.com.
Matthijs M VersteeghInstitute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, Rotterdam, The Netherlands.
Irene SantiInstitute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, Rotterdam, The Netherlands.
Jan BusschbachSection of Medical Psychology and Psychotherapy, Erasmus MC, Rotterdam, The Netherlands.
Judit SimonDepartment of Health Economics, Center for Public Health, Medical University of Vienna, Vienna, Austria. judit.simon@meduniwien.ac.at.
Leona Hakkaart-van RoijenErasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands. hakkaart@eshpm.eur.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesCountry-specific value sets for the EQ-5D are available which reflect preferences for health states elicited from the general population. This allows the transformation of responses on EQ-5D to health state utility values. Only twelve European countries possess country-specific value sets and no value set reflecting the preferences of Europe exists. We aim to estimate a 'pan-European' value set for the EQ-5D-3L, reflecting the preferences for health states of the European population that could help to evaluate health care from the perspective of the European decision-maker.

methodsWe systematically assessed and compared the methodologies of available EQ-5D-3L time trade-off (TTO) value sets from twelve European countries: Denmark, France, Germany, Hungary, Italy, Netherlands, Poland, Portugal, Romania, Slovenia, Spain and UK. Using their published coefficients, a dataset with utility values for all 243 health states was simulated. Different modelling techniques and model specifications including interaction terms were tested. Model selection was based on goodness-of-fit criteria. We also explored results with application of population size weights.

resultsMethodological, procedural and analytical characteristics of the included EQ-5D-3L valuation studies were quite comparable. An OLS based model was the preferred model to represent European preferences. Weighting with population size made little difference.

conclusionsEQ-5D-3L valuation studies were considered of sufficient comparability to form the basis for a new 'pan-European' value set. The method used allows for an easy update when new national value sets become available.

Indexed as

Health StatusQuality of LifeEuropeGermanyHumansSurveys and QuestionnairesEQ-5D-3LEuropeTime trade-offUtilitiesValue set

Identifiers

PMID36635625
PMCPMC9835298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.